Erlotinib Study for Myelodysplastic Syndrome (MDS)
Clinical trial NCT00977548 · COMPLETED
Trial details
- NCT number
- NCT00977548
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-01
- Primary completion
- 2012-06-01
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.